FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1682432998> ?p ?o ?g. }

• W1682432998 endingPage "455" @default.
• W1682432998 startingPage "447" @default.
• W1682432998 abstract "The contributions of various functional groups to the pharmacophore of the N-type calcium-channel blocker, ω-conotoxin GVIA (GVIA), have been investigated using structural and in-vitro functional studies of analogues substituted at one or two positions with non-native residues. In most cases the structure of the analogue was shown to be native-like by 1H NMR spectroscopy. Minor conformational changes observed in some cases were characterized by two-dimensional NMR. Three functional assays (sympathetic nerve stimulation of rat isolated vas deferens, right atrium and mesenteric artery) were employed to monitor N-type calcium-channel activity. The data provide a more detailed picture of the roles in GVIA structure and activity of the crucial Lys2 and Tyr13, as well as all other positively charged residues, Tyr22, the hydroxyproline residues and the C-terminal amido moiety, many of which were identified as being important for activity in an alanine scan [Lew et al. (1997) J. Biol. Chem.272, 12014–12023]. Substitutions of Lys2 with nonstandard amino acids and arginine quantified the roles of the length and charge of the Lys side chain. The orientation of the Tyr13 side chain and its hydroxyl moiety was shown to be important by substitution with d-Tyr and the d-form and l-form of the constrained analogue 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid [Tic(OH)]. The roles of the Hyp10 and Hyp21 hydroxyl groups, investigated by proline substitutions, appear to be more structural (as monitored by NMR) than functional, although small decreases in potency were observed in some assays. The reversibility of the channel blockade was also studied, and several analogues with faster wash-out characteristics than native GVIA were identified. Rapid reversibility (as in the case of ω-conotoxin MVIIA) may be beneficial for therapeutic applications. Disubstituted analogues revealed some interesting cooperative effects, which were not predicted from single-residue substitutions. A disubstituted chimera of GVIA and ω-conotoxin MVIIA was more potent than either native molecule. The more detailed description of the GVIA pharmacophore obtained here provides a better basis for the future design of truncated peptide and peptidomimetic analogues." @default.
• W1682432998 created "2016-06-24" @default.
• W1682432998 creator A5003460070 @default.
• W1682432998 creator A5024326612 @default.
• W1682432998 creator A5028183600 @default.
• W1682432998 creator A5039797008 @default.
• W1682432998 creator A5051162345 @default.
• W1682432998 creator A5060762482 @default.
• W1682432998 date "1999-06-01" @default.
• W1682432998 modified "2023-09-27" @default.
• W1682432998 title "Roles of key functional groups in omega-conotoxin GVIA. Synthesis, structure and functional assay of selected peptide analogues" @default.
• W1682432998 cites W1481413807 @default.
• W1682432998 cites W1966121553 @default.
• W1682432998 cites W1968124094 @default.
• W1682432998 cites W1973993174 @default.
• W1682432998 cites W1988277442 @default.
• W1682432998 cites W1993176839 @default.
• W1682432998 cites W2014803874 @default.
• W1682432998 cites W2021963361 @default.
• W1682432998 cites W2022503583 @default.
• W1682432998 cites W2036209063 @default.
• W1682432998 cites W2049318934 @default.
• W1682432998 cites W2050823731 @default.
• W1682432998 cites W2055097743 @default.
• W1682432998 cites W2058527555 @default.
• W1682432998 cites W2059249994 @default.
• W1682432998 cites W2061761037 @default.
• W1682432998 cites W2064964695 @default.
• W1682432998 cites W2066787103 @default.
• W1682432998 cites W2069775711 @default.
• W1682432998 cites W2078673681 @default.
• W1682432998 cites W2081544730 @default.
• W1682432998 cites W2083030813 @default.
• W1682432998 cites W2083666271 @default.
• W1682432998 cites W2119985159 @default.
• W1682432998 cites W4251169296 @default.
• W1682432998 cites W4255969386 @default.
• W1682432998 doi "https://doi.org/10.1046/j.1432-1327.1999.00383.x" @default.
• W1682432998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10336629" @default.
• W1682432998 hasPublicationYear "1999" @default.
• W1682432998 type Work @default.
• W1682432998 sameAs 1682432998 @default.
• W1682432998 citedByCount "55" @default.
• W1682432998 countsByYear W16824329982012 @default.
• W1682432998 countsByYear W16824329982013 @default.
• W1682432998 countsByYear W16824329982014 @default.
• W1682432998 countsByYear W16824329982015 @default.
• W1682432998 countsByYear W16824329982016 @default.
• W1682432998 countsByYear W16824329982017 @default.
• W1682432998 countsByYear W16824329982018 @default.
• W1682432998 countsByYear W16824329982019 @default.
• W1682432998 countsByYear W16824329982021 @default.
• W1682432998 countsByYear W16824329982022 @default.
• W1682432998 crossrefType "journal-article" @default.
• W1682432998 hasAuthorship W1682432998A5003460070 @default.
• W1682432998 hasAuthorship W1682432998A5024326612 @default.
• W1682432998 hasAuthorship W1682432998A5028183600 @default.
• W1682432998 hasAuthorship W1682432998A5039797008 @default.
• W1682432998 hasAuthorship W1682432998A5051162345 @default.
• W1682432998 hasAuthorship W1682432998A5060762482 @default.
• W1682432998 hasConcept C104264131 @default.
• W1682432998 hasConcept C124790011 @default.
• W1682432998 hasConcept C133571119 @default.
• W1682432998 hasConcept C155647269 @default.
• W1682432998 hasConcept C178790620 @default.
• W1682432998 hasConcept C185592680 @default.
• W1682432998 hasConcept C2776568683 @default.
• W1682432998 hasConcept C2779281246 @default.
• W1682432998 hasConcept C2779856020 @default.
• W1682432998 hasConcept C515207424 @default.
• W1682432998 hasConcept C519063684 @default.
• W1682432998 hasConcept C55493867 @default.
• W1682432998 hasConcept C56173144 @default.
• W1682432998 hasConcept C66974803 @default.
• W1682432998 hasConcept C71240020 @default.
• W1682432998 hasConcept C85520022 @default.
• W1682432998 hasConceptScore W1682432998C104264131 @default.
• W1682432998 hasConceptScore W1682432998C124790011 @default.
• W1682432998 hasConceptScore W1682432998C133571119 @default.
• W1682432998 hasConceptScore W1682432998C155647269 @default.
• W1682432998 hasConceptScore W1682432998C178790620 @default.
• W1682432998 hasConceptScore W1682432998C185592680 @default.
• W1682432998 hasConceptScore W1682432998C2776568683 @default.
• W1682432998 hasConceptScore W1682432998C2779281246 @default.
• W1682432998 hasConceptScore W1682432998C2779856020 @default.
• W1682432998 hasConceptScore W1682432998C515207424 @default.
• W1682432998 hasConceptScore W1682432998C519063684 @default.
• W1682432998 hasConceptScore W1682432998C55493867 @default.
• W1682432998 hasConceptScore W1682432998C56173144 @default.
• W1682432998 hasConceptScore W1682432998C66974803 @default.
• W1682432998 hasConceptScore W1682432998C71240020 @default.
• W1682432998 hasConceptScore W1682432998C85520022 @default.
• W1682432998 hasIssue "2" @default.
• W1682432998 hasLocation W16824329981 @default.
• W1682432998 hasLocation W16824329982 @default.
• W1682432998 hasOpenAccess W1682432998 @default.
• W1682432998 hasPrimaryLocation W16824329981 @default.
• W1682432998 hasRelatedWork W1174417420 @default.

• next